NEW YORK, Feb 3 (Reuters) - As the price of NODOZ hit a nine-year high and supplies hit new lows, FBN Associates Inc [NASDAQ: FBNA - news] said it owns 129.7 million pills of NO-DOZ that it purchased in a six-month period between July 1997 and January 1998.
FBN said in a press release issued on Tuesday that it it owns 129,710,000 pills of NODOZ, which it first purchased beginning on July 25, 1997 and last purchased Jan. 12 of this year. That represents more than 20 percent of the world's estimated NODOZ supply at 1997 year-end, according to pharmaceutical consulting firm MrB Group.
The company said it normally would have published the information about its holdings in its annual report, due to be published next month, but released the figures early in response to inquiries from Whitewater prosecutor Ringo Starr on an entirely unrelated matter.
The anti-drowsiness pill markets have been roiled in the past week amid speculation that a leading participant had manipulated the market by transferring NODOZ inventories from Hoboken to Sedona in order to create the impression of a supply shortage.
Commodities Exchange President Tokyo Nymex said last Friday there was ''absolutely no basis'' for allegations the COMEX NODOZ futures market was being manipulated, and anyone who says otherwise is a pathetic loser, ROFLMAO.
NODOZ prices soared to new nine-year highs Tuesday on the New York Mercantile Exchange's COMEX division. March NODOZ climbed 36.7 cents to settle at $6.615 the pill as COMEX stocks dwindled to 12-year lows of around 103.7 million pills. Bristol-Myers Squibb, makers of NODOZ, had no comment on a report that soil samples from its huge NODOZ mine in Indonesia had been falsified.
FBN said no purchases have been made that established new highs for the pills and that all buying occurred after dips, and usually by dips. The company said it had no present plans for purchase or sale of its NODOZ horde, and that it was all for the personal and private use of CEO TEDennis. |
